Puma Biotechnology, Inc.
Hedge Funds Holdings
Last updated:
Puma Biotechnology, Inc.‘s stocks are currently a part of 71 hedge funds’ portfolios, which represents 60.21% of the total amount of its stocks outstanding. This makes up a total of 27.31M shares of Puma Biotechnology, Inc.. Compared to the previous quarter, the number fell by -2.11% or -588.22K shares fewer. As for the holding position changes, 29.58% (21) of current hedge fund investors increased the number of shares held, 39.44% (28) of current holders sold a part of the shares held, and 14.08% (10) closed the holdings completely. 5 hedge funds are new holders of Puma Biotechnology, Inc. stock in Q3 2022, it is 7.04% of total holders.
Hedge funds holding Puma Biotechnology (Q4 2017 – Q3 2022)
| Q4 2017 | 199 |
|---|---|
| Q1 2018 | 171 |
| Q2 2018 | 170 |
| Q3 2018 | 155 |
| Q4 2018 | 137 |
| Q1 2019 | 157 |
| Q2 2019 | 137 |
| Q3 2019 | 139 |
| Q4 2019 | 130 |
| Q1 2020 | 121 |
| Q2 2020 | 125 |
| Q3 2020 | 128 |
| Q4 2020 | 122 |
| Q1 2021 | 117 |
| Q2 2021 | 120 |
| Q3 2021 | 117 |
| Q4 2021 | 99 |
| Q1 2022 | 98 |
| Q2 2022 | 81 |
| Q3 2022 | 71 |
Hedge funds changes in Puma Biotechnology positions (Q4 2017 – Q3 2022)
| Q4 2017 | 49 | 76 | 56 | 19 | -1 |
|---|---|---|---|---|---|
| Q1 2018 | 23 | 83 | 51 | 48 | -34 |
| Q2 2018 | 24 | 70 | 55 | 25 | -4 |
| Q3 2018 | 22 | 60 | 49 | 36 | -12 |
| Q4 2018 | 27 | 45 | 49 | 44 | -28 |
| Q1 2019 | 41 | 52 | 44 | 21 | -1 |
| Q2 2019 | 23 | 60 | 31 | 40 | -17 |
| Q3 2019 | 33 | 55 | 27 | 32 | -8 |
| Q4 2019 | 19 | 57 | 36 | 26 | -8 |
| Q1 2020 | 17 | 42 | 42 | 25 | -5 |
| Q2 2020 | 27 | 45 | 35 | 23 | -5 |
| Q3 2020 | 25 | 36 | 44 | 20 | 3 |
| Q4 2020 | 15 | 38 | 41 | 21 | 7 |
| Q1 2021 | 11 | 44 | 43 | 15 | 4 |
| Q2 2021 | 16 | 47 | 39 | 13 | 5 |
| Q3 2021 | 12 | 51 | 35 | 15 | 4 |
| Q4 2021 | 20 | 38 | 32 | 38 | -29 |
| Q1 2022 | 17 | 26 | 40 | 17 | -2 |
| Q2 2022 | 15 | 20 | 34 | 31 | -19 |
| Q3 2022 | 5 | 21 | 28 | 10 | 7 |
Hedge funds changes in Puma Biotechnology stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 72,488,000 | 77,809,000 |
|---|---|---|
| Q1 2018 | 29,560,000 | 38,060,000 |
| Q2 2018 | 82,146,000 | 81,959,000 |
| Q3 2018 | 35,416,000 | 32,850,000 |
| Q4 2018 | 5,865,000 | 11,220,000 |
| Q1 2019 | 33,210,000 | 20,134,000 |
| Q2 2019 | 5,050,000 | 2,876,000 |
| Q3 2019 | 6,450,000 | 7,836,000 |
| Q4 2019 | 6,831,000 | 6,207,000 |
| Q1 2020 | 3,453,000 | 3,807,000 |
| Q2 2020 | 2,218,000 | 3,858,000 |
| Q3 2020 | 2,157,000 | 3,335,000 |
| Q4 2020 | 4,305,000 | 3,170,000 |
| Q1 2021 | 726,000 | 569,000 |
| Q2 2021 | 1,126,000 | 696,000 |
| Q3 2021 | 878,000 | 441,000 |
| Q4 2021 | 725,000 | 519,000 |
| Q1 2022 | 211,000 | 573,000 |
| Q2 2022 | 231,000 | 161,000 |
| Q3 2022 | 1,069,000 | 134,000 |